The number of individual cases identified in EudraVigilance for COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19) is 552,679 (up to 18/02/2024)
Evaluating Condition
Number of individual cases by Age Group
Pivot Table Prompts
Sections
Age Group
Cases
%
Not Specified
37,992
6.9%
0-1 Month
311
0.1%
2 Months - 2 Years
347
0.1%
3-11 Years
284
0.1%
12-17 Years
331
0.1%
18-64 Years
430,098
77.8%
65-85 Years
80,078
14.5%
More than 85 Years
3,238
0.6%
Total
552,679
100.0%
saw.dll?DocPart&StateID=1198724609
Evaluating Condition
Number of individual cases by Sex
Pivot Table Prompts
Sections
Sex
Cases
%
Female
385,693
69.8%
Male
150,567
27.2%
Not Specified
16,419
3.0%
Total
552,679
100.0%
saw.dll?DocPart&StateID=1198724610
Evaluating Condition
Number of individual cases by Geographic Origin (EEA/Non-EEA)
Pivot Table Prompts
Sections
Occurrence Country EEA/Non EEA
Cases
%
European Economic Area
342,107
61.9%
Non European Economic Area
210,572
38.1%
Not Specified
0
Total
552,679
100.0%
saw.dll?DocPart&StateID=1198724611
Evaluating Condition
Number of individual cases by Reporter Group
Pivot Table Prompts
Sections
Reporter Group
Cases
%
Healthcare Professional
180,720
32.7%
Non Healthcare Professional
371,959
67.3%
Not Specified
0
Total
552,679
100.0%
saw.dll?DocPart&StateID=1198724612
Evaluating Condition
For the interpretation of the results, please refer to the key considerations at www.adrreports.eu
Evaluating Condition
Move a group to the "Groups with Permission" area to allow members to use this Saved Customization. Check the box next to a group to make this Saved Customization its default.
